Scandinavia: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Scandinavia

The Scandinavia medicaments containing hormones market reached $X in 2023, approximately mirroring the previous year. Over the period under review, consumption continues to indicate resilient growth. Over the period under review, the market attained the maximum level in 2023 and is likely to continue growth in the immediate term.

Medicaments Containing Hormones Production in Scandinavia

In value terms, medicaments containing hormones production reached $X in 2023 estimated in export price. The total production indicated prominent growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, production decreased by X% against 2020 indices. The most prominent rate of growth was recorded in 2019 with an increase of X% against the previous year. The level of production peaked at $X in 2020; however, from 2021 to 2023, production failed to regain momentum.

Medicaments Containing Hormones Exports

Exports in Scandinavia

Medicaments containing hormones exports dropped markedly to X tons in 2023, falling by X% on 2022. Over the period under review, exports, however, continue to indicate a strong increase. The growth pace was the most rapid in 2018 when exports increased by X%. As a result, the exports attained the peak of X tons. From 2019 to 2023, the growth of the exports remained at a lower figure.

In value terms, medicaments containing hormones exports skyrocketed to $X in 2023. In general, exports, however, showed a strong expansion. The most prominent rate of growth was recorded in 2018 when exports increased by X%. Over the period under review, the exports attained the peak figure in 2023 and are likely to see steady growth in the near future.

Exports by Country

In 2023, Sweden (X tons) represented the key exporter of medicaments containing hormones but not antibiotics in Scandinavia, achieving X% of total export.

Sweden was also the fastest-growing in terms of the medicaments containing hormones but not antibiotics exports, with a CAGR of X% from 2012 to 2023. From 2012 to 2023, the share of Sweden increased by X percentage points, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Sweden ($X) also remains the largest medicaments containing hormones supplier in Scandinavia.

From 2012 to 2023, the average annual growth rate of value in Sweden amounted to X%.

Export Prices by Country

In 2023, the export price in Scandinavia amounted to $X per ton, increasing by X% against the previous year. Over the period under review, the export price showed a relatively flat trend pattern. The growth pace was the most rapid in 2015 an increase of X% against the previous year. Over the period under review, the export prices reached the peak figure at $X per ton in 2013; however, from 2014 to 2023, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Sweden.

From 2012 to 2023, the rate of growth in terms of prices for Sweden amounted to X% per year.

Medicaments Containing Hormones Imports

Imports in Scandinavia

In 2023, supplies from abroad of medicaments containing hormones but not antibiotics increased by X% to X tons, rising for the fifth consecutive year after two years of decline. Overall, imports enjoyed a strong increase. The pace of growth appeared the most rapid in 2014 with an increase of X% against the previous year. Over the period under review, imports hit record highs at X tons in 2016; however, from 2017 to 2023, imports stood at a somewhat lower figure.

In value terms, medicaments containing hormones imports skyrocketed to $X in 2023. In general, imports showed a significant expansion. The most prominent rate of growth was recorded in 2014 with an increase of X%. The level of import peaked in 2023 and is likely to see steady growth in the near future.

Imports by Country

Sweden represented the key importer of medicaments containing hormones but not antibiotics in Scandinavia, with the volume of imports resulting at X tons, which was near X% of total imports in 2023. It was distantly followed by Norway (X tons), comprising a X% share of total imports.

Imports into Sweden increased at an average annual rate of X% from 2012 to 2023. At the same time, Norway (X%) displayed positive paces of growth. Moreover, Norway emerged as the fastest-growing importer imported in Scandinavia, with a CAGR of X% from 2012-2023. While the share of Norway (X p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Norway ($X) and Sweden ($X) appeared to be the countries with the highest levels of imports in 2023.

Norway, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review.

Import Prices by Country

The import price in Scandinavia stood at $X per ton in 2023, rising by X% against the previous year. Over the period under review, the import price saw a buoyant increase. The most prominent rate of growth was recorded in 2013 when the import price increased by X%. The level of import peaked in 2023 and is expected to retain growth in the near future.

There were significant differences in the average prices amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was Norway ($X per ton), while Sweden amounted to $X per ton.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Sweden (X%).

Source: IndexBox Platform